Treatment of hyperproliferative diseases

Details for Australian Patent Application No. 2006203668 (hide)

Owner Molecular Skincare Limited

Inventors Bavik, Claes; Tazi-Ahnini, Rachid; Cork, Michael; Ward, Simon

Agent Pizzeys

Pub. Number AU-B-2006203668

Parent 2001278632

Filing date 24 August 2006

Wipo publication date 14 September 2006

Acceptance publication date 22 May 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 31/10 (2006.01)

A61K 31/11 (2006.01) - Aldehydes

A61K 31/145 (2006.01) - having sulfur atoms, e.g. thiurams (NC(S)SC(S)N or NC(S)SSC(S)N)

A61K 31/285 (2006.01)

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/02 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 5/16 (2006.01) Drugs for disorders of the endocrine system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 Drugs for dermatological disorders

Event Publications

7 September 2006 Complete Application Filed

14 September 2006 Application Open to Public Inspection

  Published as AU-B-2006203668

22 May 2008 Application Accepted

  Published as AU-B-2006203668

10 July 2008 Alteration of Name

  The name of the applicant has been altered to York Pharma (R&D) Limited

18 September 2008 Standard Patent Sealed

21 April 2011 Assignment Registered

  York Pharma (R&D) Limited The patent has been assigned to Vampex Limited

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203669-Slider Device, Package, and Method of Mounting

2006203667-Method and apparatus for transmission rate modification of communication channels